Integrin antagonists
US6552079B2 · kind B2 · utility
3Cited by
3References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2001 |
| Grant date | Apr 22, 2003 |
| Priority date | — |
| Expiry date | Sep 4, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel compounds, their salts and compositions related thereto having activity against mammalian integrins are disclosed. The compounds are useful in vitro or in vivo for preventing or treating thrombotic or restenotic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.